Laparoscopic Oocyte Retrieval and Cryopreservation during Vaginoplasty for Treatment of Mayer-Rokitansky-Kuster-Hauser Syndrome
May 10th, 2022
4.6K views
A dedicated team can offer Mayer-Rokitansky-Kuster-Hauser patients the option to perform controlled ovarian stimulation and oocyte cryopreservation at the time of laparoscopic vaginoplasty.
Overview
This study presents a novel approach for treating Mayer-Rokitansky-Kuster-Hauser syndrome by combining laparoscopic vaginoplasty with oocyte retrieval. This method minimizes invasive procedures and allows for future fertility options.
Key Study Components
Area of Science
- Gynecology
- Reproductive Medicine
- Minimally Invasive Surgery
Background
- Mayer-Rokitansky-Kuster-Hauser syndrome affects female reproductive anatomy.
- Traditional treatments often require multiple invasive procedures.
- Combining surgeries can improve patient outcomes.
- Oocyte cryopreservation is crucial for future fertility.
Purpose of Study
- To evaluate a combined surgical approach for MRKH patients.
- To assess the feasibility of oocyte retrieval during vaginoplasty.
- To minimize the need for multiple anesthetics and surgeries.
Methods Used
- Controlled ovarian stimulation initiated on day 14 post-surgery.
- Monitoring of ovarian response via transabdominal ultrasound.
- Measurement of estradiol and progesterone levels.
- Establishment of pneumoperitoneum using an open technique.
Main Results
- Successful retrieval of oocytes during laparoscopic vaginoplasty.
- Single anesthesia requirement improved patient comfort.
- Enhanced feasibility for younger patients.
- Demonstrated effectiveness of the combined approach.
Conclusions
- The combined approach is a viable option for MRKH patients.
- It reduces the invasiveness of treatment.
- Future fertility options can be preserved effectively.
Frequently Asked Questions
What is Mayer-Rokitansky-Kuster-Hauser syndrome?
It is a congenital condition affecting the female reproductive system, leading to the absence of the uterus and upper two-thirds of the vagina.
How does the combined procedure work?
It involves performing laparoscopic vaginoplasty while simultaneously retrieving oocytes for cryopreservation.
What are the benefits of this approach?
It minimizes the need for multiple surgeries and anesthetics, making it less invasive and more comfortable for patients.
Who are the key professionals involved in this procedure?
The procedure is performed by a senior gynecologist and clinical embryologists specializing in assisted reproduction.
When is ovarian stimulation initiated?
Ovarian stimulation is started on day 14 following the surgery.
What monitoring is involved during the procedure?
Ovarian response is monitored through serial transabdominal ultrasounds and hormone level measurements.
Executive Industry Relevance
Integrating laparoscopic oocyte retrieval with vaginoplasty in Mayer-Rokitansky-Kuster-Hauser syndrome (MRKHS) patients addresses a critical challenge in fertility preservation for individuals with complex reproductive anatomy. This combined approach reduces procedural invasiveness and anesthesia exposure, supporting translational continuity from surgical intervention to assisted reproductive technology pipelines. The method enables reliable access to mature oocytes for cryopreservation, directly impacting future fertility options and portfolio strategies in reproductive medicine R&D.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables functional validation of ovarian response and oocyte maturation in anatomically complex patient populations.
- Supports mechanistic de-risking by demonstrating feasibility of oocyte retrieval in non-standard surgical contexts.
- Provides a platform for evaluating ovarian stimulation protocols in rare gynecological syndromes.
Screening & Assay Development
- Standardizes follicular aspiration and oocyte handling for downstream embryology workflows.
- Ensures reproducible collection and vitrification of metaphase II oocytes for future ART applications.
- Facilitates quantitative assessment of oocyte yield and maturation stage as key performance metrics.
Translational & Preclinical Research
- Aligns surgical and laboratory procedures to maximize translational continuity from patient to cryopreserved biological material.
- Enables risk-adjusted advancement of fertility preservation strategies in rare disease cohorts.
- Supports the development of disease-relevant protocols for reproductive tissue handling and preservation.
Pipeline & Workflow Integration
This method bridges surgical intervention and assisted reproduction, positioning oocyte retrieval and cryopreservation as an integrated workflow within the fertility preservation continuum for MRKHS patients.
- Discovery Biology: Validates ovarian stimulation and retrieval protocols in anatomically atypical settings.
- Screening: Delivers standardized, reproducible oocyte collection and vitrification outputs for laboratory analysis.
- Analytics: Provides quantitative readouts on oocyte yield, maturation, and cryopreservation success.
- Translational Research: Ensures continuity from surgical retrieval to laboratory cryostorage, supporting future ART interventions.
- Enterprise Reuse: Establishes a reusable protocol for combined surgical and fertility preservation procedures in rare gynecological syndromes.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in oocyte viability and retrieval success in complex patient populations.
- Operational Value: Reduces procedural redundancy, anesthesia exposure, and overall patient risk.
- Strategic Value: Enables more efficient go/no-go decisions for fertility preservation in rare disease settings.
- Portfolio Impact: Supports risk-adjusted prioritization of fertility preservation protocols for broader clinical translation.
Implementation Considerations
- Requires multidisciplinary expertise in minimally invasive gynecologic surgery and embryology.
- Demands access to advanced laparoscopic instrumentation and controlled laboratory cryopreservation infrastructure.
- Necessitates rigorous cross-team standardization for specimen handling and identity verification.
- May require adaptation of protocols for different anatomical or disease contexts within reproductive medicine.
- Careful intraoperative technique is essential to minimize ovarian trauma and optimize oocyte yield.
Biopharma FAQs
Why is null hypothesis testing critical for oocyte yield validation?
Null hypothesis testing enables objective assessment of whether observed oocyte yields during combined laparoscopic retrieval and vaginoplasty differ from expected outcomes, supporting robust target validation for fertility preservation protocols.
How does independent variable isolation improve ovarian stimulation assessment?
Isolating variables such as stimulation protocol and timing allows teams to attribute oocyte maturation and retrieval outcomes specifically to controlled interventions, enhancing discovery-stage confidence in protocol optimization.
What do quantitative metaphase II oocyte counts enable in R&D?
Quantitative measurement of metaphase II oocytes provides actionable data for benchmarking protocol efficiency, informing downstream ART workflows, and supporting cross-study comparisons in fertility preservation research.
Why are replication requirements important for cross-team protocol adoption?
Replication ensures that oocyte retrieval and cryopreservation outcomes are consistent across surgical and laboratory teams, facilitating reliable protocol transfer and broader adoption in multi-center R&D environments.
Which statistical analyses are required before protocol implementation?
Statistical analyses of oocyte yield, maturation rates, and complication frequencies are essential to validate reproducibility and safety, supporting evidence-based implementation of combined surgical and fertility preservation protocols.
Chapters in this video
0:04
Introduction
0:53
Clinical Procedure (Laparoscopy): Oocyte Retrieval
2:16
Clinical Procedure (Laparoscopy): Vaginoplasty
4:53
IVF Laboratory: Oocyte Retrieval Procedure
5:48
Oocyte Denudation
7:12
Oocyte Vitrification
10:31
Results: Combined Laparoscopic Procedure of Oocyte Retrieval and Vaginoplasty
11:26
Conclusion
